The Application Of Microneedles in Perioperative Pain And Drug Management

I. Introduction: A New Dimension in Perioperative Management
Perioperative management encompasses the entire process from preoperative assessment, intraoperative procedures to postoperative rehabilitation, with one of its core goals being to ensure patient safety, comfort and optimize prognosis. Pain management and precise drug administration are key components. Traditional methods such as oral analgesics have drawbacks like slow onset and systemic side effects, while intramuscular or intravenous injections are associated with pain, inconvenience and potential infection risks. Microneedle technology, with its painless, minimally invasive and locally precise controlled-release characteristics, offers a highly promising solution for revolutionizing perioperative pain and drug management strategies. This article will delve into how microneedles can play a unique role in the preoperative and postoperative stages through transdermal drug delivery in local anesthesia, analgesia, anti-inflammation and prevention of complications.
II. Preoperative Application: Painless Pre-anesthesia and Anti-anxiety
The preoperative tension and anxiety of patients can raise the pain threshold and affect the cooperation during surgery. Microneedles can play a role in sedation and preemptive analgesia before surgery.
1. Local anesthesia and preoperative analgesia: For many superficial surgeries (such as skin tumor removal, skin graft harvesting, and some cosmetic procedures), or as an adjunct to regional blocks, soluble microneedle patches loaded with local anesthetics (such as lidocaine and prilocaine) can be used. Patients apply the patches to the planned incision or treatment area before the operation. The microneedles dissolve on the skin surface within a few minutes, precisely delivering the anesthetic to the nerve endings in the dermis, achieving efficient and long-lasting surface anesthesia. Compared with traditional topical anesthetic creams, microneedle patches can overcome the stratum corneum barrier, allowing the drug to directly act on the target site, with faster onset and more reliable effects, and without the need for occlusion, making them more convenient to use. This can significantly reduce intraoperative pain, decrease the dosage of general anesthetics, and is particularly suitable for children and sensitive patients who are afraid of injections.
2. Delivery of anti-anxiety and sedative drugs: For patients with extreme anxiety, researchers are exploring the possibility of transdermal delivery of sedative drugs (such as dexmedetomidine) through microneedles. By designing a sustained-release microneedle system, the drug can be applied several hours before the operation, allowing it to be absorbed through the skin at a stable rate, producing a mild sedative and anti-anxiety effect, helping patients enter the operating room with a calmer state of mind and avoiding cardiovascular fluctuations caused by tension.
III. Postoperative Application: Precise Analgesia and Rehabilitation Support
Postoperative pain management directly affects the recovery speed, satisfaction and functional rehabilitation of patients. The application of microneedles in the postoperative stage is more revolutionary.
1. Long-term postoperative analgesia: The control of acute postoperative pain is of critical importance. Soluble microneedles or hollow microneedles (acting as microinfusion devices) can be loaded with potent analgesics such as opioids (fentanyl, sufentanil) or transdermal formulations of non-steroidal anti-inflammatory drugs (NSAIDs). When applied near the surgical site, the drugs can act directly on the local area, creating a high concentration around the wound, effectively blocking pain signals while maintaining a relatively low systemic drug concentration. This significantly reduces the risks of opioid-induced side effects such as nausea, vomiting, constipation, respiratory depression, and addiction. This "local administration with minimal systemic side effects" approach is a perfect embodiment of the multimodal postoperative analgesia concept. It is particularly suitable for patients undergoing joint replacement, hernia repair, and breast surgery, where postoperative pain is pronounced.

2. Targeted anti-inflammation and prevention of complications: Postoperative inflammatory responses are the main causes of pain and swelling, and excessive inflammation can also affect healing. Microneedle systems loaded with NSAIDs (such as diclofenac, ketoprofen) or corticosteroids (such as dexamethasone) can target the surgical site, strongly inhibiting the release of local inflammatory mediators such as prostaglandins, effectively reducing redness, swelling, heat, and pain, and accelerating the resolution of swelling. For patients at risk of thrombosis, research is also exploring the possibility of local prevention through transdermal delivery of anticoagulant drugs (such as heparin) via microneedles.

3. Localized and precise delivery of antibiotics: Preventing surgical site infections (SSIs) is a key focus in postoperative management. In clean-contaminated or contaminated wounds, or for patients at high risk of infection, microneedle patches loaded with antibiotics (such as mupirocin, fusidic acid) can be applied around the incision after suturing. This creates a high concentration of antibiotics in the local area of the incision, effectively killing or inhibiting bacterial growth, preventing superficial infections, while avoiding the side effects of systemic antibiotic use, such as intestinal flora imbalance.
IV. Technical Advantages, Challenges and the Future
Advantages:
* Painless or minimally painful: The needle is very small and does not touch the pain nerves, providing a comfortable experience.
* Patient-controlled: The patch form is convenient for patients to use by themselves, enhancing convenience.
* Continuous and stable release: It can be designed as a sustained-release system, providing a stable drug concentration for several hours to several days.
* Strong targeting and few side effects: The drug mainly acts locally, with low systemic exposure.
* Improved compliance: It avoids the inconvenience and fear of repeated injections.
Challenge:
* Drug loading limit: The single-dose administration is restricted by the size and number of microneedles, making it currently more suitable for highly effective drugs.
* Drug stability: Some drugs may lose their activity during the manufacturing or storage of microneedles.
* Individual skin differences: Skin thickness, moisture, and other factors may affect the consistency of drug penetration.
* Regulatory and cost considerations: As a new drug delivery device, its approval process is strict, and the initial cost may be relatively high.
Future Outlook: With the development of intelligent microneedle systems, responsive microneedles that can "on-demand" release drugs based on changes in local tissue pH, temperature, or specific enzyme activity may emerge in the future. For instance, anti-inflammatory drugs could be automatically released when elevated inflammatory markers are detected, or analgesics could be released upon sensing pain signals. Additionally, the integration of microneedles with sensors could enable real-time monitoring and feedback treatment of local physiological and biochemical indicators after surgery.
In conclusion, the application of microneedle technology in perioperative drug management represents a paradigm shift from "systemic medication and coarse management" to "local precision and on-demand delivery". Although it cannot completely replace all traditional drug administration routes, it provides a powerful innovative tool for optimizing the patient experience, enhancing the safety of pain relief, and preventing complications. It is expected to become one of the standard configurations in future Enhanced Recovery After Surgery (ERAS) and comfortable medical care plans.